VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹1.24 Cr | ₹0.62 Cr | ₹0.67 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VALIANT LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹1.24 Cr |
| Mar2024 | ₹0.62 Cr |
| Mar2023 | ₹0.67 Cr |
How is Deferred Tax Assets / Liabilities of VALIANT LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.24 Cr | 100.97 | |
| Mar2024 | ₹0.62 Cr | -7.21 | |
| Mar2023 | ₹0.67 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹369.2 Cr | -2% | -12.3% | -38.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -2% |
-12.3% |
-38.2% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses